Refining Your Drug Candidates Through Pre-Clinical Lead Optimization to Ensure Translational Success

Time: 2:00 pm
day: Workshop C


Refining potential drug targets before they advance to costly and time-intensive clinical trials is important. With more organizations working across novel targeting agents, further radioisotopes, new linkers and chelators – lead optimization is integral for translational success leading to the development of safer and more effective drugs for patients.

Join this interactive workshop to hear more on:

  • Uncovering preclinical evaluation processes to select efficiently good radiolabeled molecules
  • Assessing the addition of linkers and choice of chelating agent
  • Screening combinations of radiometal complexes, linker and conjugation function
  • Novel platforms to design new molecules
  • Enhancing PKPD, binding affinity and biodistribution